Biogelx is an early stage biomaterials company. The company designs a range of peptide hydrogels that can mimic the properties of various tissue types. The hydrogels are composed of functional peptides that are synthesised in-house. Using patented technology, the peptides self-assemble to form nanofibrous networks, which ultimately create a hydrogel. These are applicable across a range of cell culture applications including cell-based assays and regenerative medicine (www.biogelx.com). These hydrogels offer a 3D environment for customers to grow their cells in a way that closely matches the natural environment that the cells experience in the body.  Biogelx has been successfully selling their products, with customers in the UK, Europe, South Korea, and more recently, the US. The company has reached an exciting time, as sales traction is increasing and the next major challenge will be to enter the US market.